High frequency of tregs after curing hepatitis c could enhance liver cancer risk
Contents The symptoms of liver cancer Faster manufacture of regulatory T cells normal with chronic hepatitis C infection didn’t go back to normal levels in several patients who was simply effectively given direct-acting antiviral (DAA) drugs, research conducted recently found. Researchers in the College of Bonn in Germany, who’ve studied CD4+ regulatory T cells for …